PHIO PHARMACEUTICALS CORP (PHIO) Stock Balance Sheet
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.39M | 8.49M | 11.78M | 24.06M | 14.24M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 474.00K | 832.00K | 670.00K | 670.00K | 920.00K | |||
| Total Current Assets | 5.86M | 9.32M | 12.45M | 24.73M | 15.16M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.00K | 39.00K | 340.00K | 420.00K | 560.00K | |||
| Other Non-Current Assets | 0.00 | 3.00K | 20.00K | 30.00K | 20.00K | |||
| Total Non-Current Assets | 1.00K | 42.00K | 360.00K | 440.00K | 580.00K | |||
| TOTAL ASSETS | 5.87M | 9.36M | 12.81M | 25.17M | 15.74M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 735.00K | 977.00K | 1.16M | 2.79M | 1.47M | |||
| Accounts Payable | 184.00K | 657.00K | 780.00K | 280.00K | 730.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 919.00K | 1.63M | 1.94M | 3.07M | 2.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 230.00K | |||
| Other Non-Current Liabilities | N/A | 0.00 | 30.00K | 170.00K | 300.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 30.00K | 170.00K | 520.00K | |||
| TOTAL LIABILITIES | 919.00K | 1.63M | 1.97M | 3.24M | 2.72M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -144.73M | -139.21M | -128.38M | -116.90M | -103.61M | |||
| Additional Paid In Capital | 149.68M | 146.94M | 139.22M | 138.83M | 116.63M | |||
| Common Shares | 100.00 | 370.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -100.00 | -370.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 958.22K | 416.37K | 1.14M | 1.13M | 480.00K | |||
| Tangible Book Value per Share | 5.16 | 18.57 | 9.51 | 19.41 | 27.13 | |||
| Total Shareholders' Equity | 4.95M | 7.73M | 10.84M | 21.93M | 13.02M | |||
| TOTAL LIABILITIES AND EQUITY | 5.87M | 9.36M | 12.81M | 25.17M | 15.74M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.02 | |||
| Current Ratio | 6.38 | 5.71 | 6.42 | 8.06 | 6.89 | |||
| Return On Assets (ROA) | -126.50% | -115.61% | -89.62% | -52.80% | -55.84% | |||
| Return On Equity (ROE) | -150.00% | -140.05% | -105.90% | -60.60% | -67.51% | |||
All data in USD , ROIC based on taxRate of 0.21